🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the best dose of glembatumumab vedotin when ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-04-20
Trial ID
NCT03326258
Treatments Being Tested
This phase II trial studies how well glembatumumab vedotin works in treatin...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2016-02-16
Trial ID
NCT02487979
Treatments Being Tested
This phase II trial studies how well glembatumumab vedotin works in treatin...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2015-09-16
Trial ID
NCT02363283
Treatments Being Tested
Patients with advanced or metastatic, gpNMB-expressing Squamous Cell Carcin...
Status
Terminated
Location
University of Miami Hospital
Start Date
2016-04-10
Trial ID
NCT02713828
Treatments Being Tested
The main purpose of this study is to see whether CDX-011 is effective in tr...
Status
Completed
Location
The University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2010-07
Trial ID
NCT01156753
Treatments Being Tested
This study will examine the effectiveness and safety of glembatumumab vedot...
Status
Terminated
Location
The Angeles Clinic and Research Institute
Start Date
2014-11
Trial ID
NCT02302339